News 2024年 04月 17日 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 2024年 02月 29日 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
News 2023年 11月 06日 Vaud-based LAGOSTA and global giant Merck collaborate on chitosan distribution Biotech company LAGOSTA has announced a collaboration with Merck. The partnership aims to facilitate the distribution of LAGOSTA's superior chito...
最新 2023年 11月 09日 瑞士Abionic和Lascco公司与菲鹏生物合作,助力中国医生诊断脓毒症 位于洛桑Biopôle生命科学园区的Abionic和Lascco公司,与中国菲鹏生物合作,利用突破性的生物标志物进行脓毒症检测,增强早期诊断能力。
Actualités 2024年 04月 17日 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
Actualités 2024年 02月 29日 Les Grands Titres de Suisse occidentale (Février 2024) D’importantes avancées en matière de semi-conducteurs et de percées dans la recherche médicale à des avancées stratégiques dans les secteurs de l...
News 2024年 01月 29日 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
News 2023年 11月 06日 Abionic and Lascco partner with Fapon for sepsis diagnosis in China Biopôle companies Abionic and Lascco team up with Fapon to harness a groundbreaking biomarker for sepsis detection, enhancing early diagnosis cap...
Actualités 2023年 09月 29日 Les Grands Titres de Suisse occidentale (Juillet-Septembre 2023) De l'élaboration de solutions éco-innovantes à des avancées pionnières dans les domaines de la technologie solaire, de la recherche sur le cancer...
News 2024年 01月 10日 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 2023年 09月 29日 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News 2023年 08月 14日 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
News 2023年 08月 07日 CDR-Life receives milestone payment CDR-Life has reached a second milestone linked to the development of its drug to combat an irreversible retinal disease. This entitles the biotec...
News 2023年 07月 31日 InSphero announces an award for 3D in vitro models InSphero, based in the canton of Zurich, and the Physicians Committee for Responsible Medicine have launched a joint award program. Five academic...
News 2023年 07月 26日 LimmaTech Bio cooperating with GSK on vaccine development The biotechnology firm LimmaTech Biologics has concluded a license agreement with GlaxoSmithKline Biologicals (GSK). In this way, LimmaTech is se...
News 2023年 06月 06日 Novocure to donate 3 million US dollars to cancer research Novocure, a biotechnology firm specializing in the field of oncology, has pledged support of 1 million US dollars per year for a period of three ...
News 2023年 06月 01日 InterAx Biotech helps Sosei Heptares with drug discovery The British pharmaceutical company Sosei Heptares has agreed a partnership with InterAx Biotech AG. It plans to use the platform of the Aargau-ba...
News 2023年 03月 15日 InSphero partners with VUB The biotechnology company InSphero has entered into a partnership with the Vrije Universiteit Brussel (VUB). A licensing agreement aims to drive ...